anabasum: Clinical Trials

1 trial of anabasum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow anabasum: new trials by email Literature Review of anabasum trials Research Report on anabasum

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Lenabasum 20 mg, Lenabasum 5 mg, Placebo - Dermatomyositis
Phase 3CompletedCorbus Pharmaceuticals Inc.1762018-12-172022-08-16

Conditions studied

Dermatomyositis (1)

Sponsors

Corbus Pharmaceuticals Inc. (1)

Countries

Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Chester V Oddis, MD (1)  ·  Victoria P Werth, MD (1)

Results publications

PMID 40383862